(BIIB) Biogen Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : (BIIB) Biogen Inc.

BIIB 154.27

+3.1%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

From: inthemoneystock	5/10/2017 12:11:59 PM
	of 3

Know This Trade Level For This Leading Bio-Tech Stock One of the leading biotechnology stocks that has been under pressure recently is Biogen Inc (NASDAQ:BIIB). This stock has been selling off since the company reported earnings on April 25th, 2017. On that day, BIIB stock traded as high as $291.90 a share. Since that time, the bio-tech giant has dropped lower by nearly $34.00. Currently, BIIB stock is trading at $258.86 a share. Traders and investors should note that the charts are signaling institutional support around the $250.00 area. This is a solid whole round number that the institutional traders and investors usually like to play. It is also a level where the stock was defended in the past. Traders should note that this trade level was chart support in late January 2017 and late October 2016. Very often, past support levels will be solid levels for bounces when retested. Nicholas Santiago InTheMoneyStocks

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext